Gain detailed device business intelligence with ‘The Gray Sheet'

Dear Colleague: Ask any business leader about the secrets to their success, and they will tell you that industry insight helps give them the edge over their competition. But why spend valuable resources searching for this information when you can let us do the work for you? Sign up for a no-obligation free trial to "The Gray Sheet" today and gain expert, in-depth analysis and coverage of breaking news, regulatory and reimbursement issues, and FDA happenings. Your one month trial will include 30 days of online access, email updates delivered to your inbox, and topical RSS feeds. Most importantly, you will catch a glimpse of what your competitors are learning every day thanks to the insight and expertise that can only be offered by "The Gray Sheet". You can also download one popular article from a recent issue, "FDA's UDI Draft Rule Details Device Marking, Database Submission Mandates". "The Gray Sheet" offers: FDA regulatory policies and activities pertaining to medical devices, including coverage of FDA advisory panel meetings, pre-market approval and post-market safety activities, and compliance issues Business news, including marketing strategies, sales and earnings, mergers and acquisitions, start-ups, partnerships and alliances New recalls in medical devices, R&D, product approvals and product launches Congressional legislative and oversight activities, key medical and regulatory meetings and conferences, and international regulatory activities Top Recent Headlines: FDA Subject To More Oversight Following User Fee Bill Passage The precise impact of the FDA legislation that passed Congress last week remains to be seen. But it does appear likely that the law will facilitate greater scrutiny by Congress and industry of the agency's device review performance and policy development. Medtronic Aims To Double Its Presence In Emerging Markets By 2015-2016 In its first in-depth investor meeting in two years, Medtronic emphasized emerging markets, its ability to demonstrate economic worth, broad product offerings and pipeline as keys to growth. J&J's Path Forward: An Interview With Alex Gorsky In this interview with Elsevier's David Cassak, J&J's new CEO talks about the company's evolving device business, the art of saying no, and potential opportunities for the health care giant. FDA Plans Fall Launch Of Device Adverse Event Smartphone App MedWatcher mobile app will facilitate device safety event reporting from doctors and patients, FDA hopes. It will also serve as a two-way communication tool for tracking device performance during a public health emergency. Best regards, Kristy J. Kennedy Elsevier Business Intelligence Medical Device Business (480) 985-9512 k.kennedy@elsevier.com    P.S. Please forward this email to any colleagues who could also benefit from this important information. This email has been sent to %%emailaddr%% by Elsevier Business Intelligence, 685 Route 202/206, Bridgewater, NJ 08807, USA. Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com %%[IF empty(EBI3_UserName) THEN]%% Update Your Email Preferences | Unsubscribe From This List %%[ELSE]%% If you no longer wish to receive promotional emails from Elsevier Business Intelligence, please update the Email Information & Offers section at the bottom of your EBI Account Profile here. %%[ENDIF]%%

You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services. If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here. BioSpace 6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S. (888) BIOSPACE